Posted by Michael Wonder on 09 Dec 2021
Canada's national strategy for drugs for rare diseases needs a holistic approach
8 December 2021 - International report summarises drugs for rare disease best practices and recommendations.
Takeda Canada has released a report on the global rare diseases policy landscape at the Forum de l'Industrie de la Santé de Québec.
Takeda's longstanding commitment to drugs for rare diseases and extensive global footprint provides a unique opportunity to assess and summarise best practices on how different countries have developed their own tailored approaches to expediting and expanding access to new treatments for rare diseases.
